Zhengduozhe Technology Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ZDZT research report →
Company
Zhengduozhe Technology Inc. , doing business as DAKOTA Life Sciences, operates as a biopharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceuticals designed to prevent and treat serious conditions arising in hospital and community settings. It principally focuses on delivering solutions to those people who are affected by antimicrobial resistance and who need pharmaceutical products at affordable prices.
- CEO
- Jingwei Zhang
- IPO
- 1995
- HQ
- Sioux Falls, SD, US
Price Chart
Valuation
- Market Cap
- $22.57K
- P/E
- -356.70
- P/S
- 0.07
- P/B
- 102.33
- EV/EBITDA
- -0.33
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 7.05%
- Op Margin
- -20.66%
- Net Margin
- -20.66%
- ROE
- -25.09%
- ROIC
- -28.69%
Growth & Income
- Revenue
- $306.19K · 33.10%
- Net Income
- $-63,262 · -182.10%
- EPS
- $-0.00 · -178.95%
- Op Income
- $-63,262
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $4.00
- 52W Low
- $0.03
- 50D MA
- $0.84
- 200D MA
- $1.19
- Beta
- 6.22
- Avg Volume
- 16
Get TickerSpark's AI analysis on ZDZT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ZDZT Coverage
We haven't published any research on ZDZT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ZDZT Report →